TLSA
Tiziana Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$0.91
−6.64%5
Insider buys (3m)
0
Insider sells (3m)
$1.0M
Net value (3m)
-19.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | CERRONE GABRIELE M · director, 10 percent owner: | Purchase | 15,000 | $1.11 |
| Aug 7, 2026 | CERRONE GABRIELE M · director, 10 percent owner: | Purchase | 42,357 | $0.99 |
| Aug 6, 2026 | Elrifi Ivor · officer: Chief Executive Officer | Purchase | 237,616 | $1.00 |
| Aug 6, 2026 | Elrifi Ivor · officer: Chief Executive Officer | Purchase | 83,807 | $0.97 |
| Aug 5, 2026 | Elrifi Ivor · officer: Chief Executive Officer | Purchase | 667,000 | $1.00 |
| Jul 23, 2026 | CERRONE GABRIELE M · director, 10 percent owner: | A-Award | 42,357 | $0.99 |
| Jun 17, 2026 | CERRONE GABRIELE M · director, 10 percent owner: | A-Award | 15,000 | $1.11 |
Institutional positioning
13F filings over the trailing two quarters
New 11Increased 15Reduced 15Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DAUNTLESS INVESTMENT GROUP, LLC | Increased | 2,165,231 | May 14, 2026 |
| Dauntless Investment Group, LLC | Reduced | 1,162,000 | Aug 13, 2026 |
| Mid-American Wealth Advisory Group, Inc. | New Position | 323,240 | Jul 16, 2026 |
| MARSHALL WACE, LLP | Reduced | 157,566 | May 15, 2026 |
| Zhang Financial LLC | Increased | 125,950 | Jul 30, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 119,238 | Aug 14, 2026 |
| ZHANG FINANCIAL LLC | Increased | 111,900 | May 6, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 110,290 | Mar 25, 2026 |
| UBS GROUP AG | Reduced | 95,700 | May 5, 2026 |
| CITADEL ADVISORS LLC | Increased | 80,222 | Sep 2, 2026 |
| COLONY GROUP, LLC | Reduced | 79,365 | May 15, 2026 |
| Focus Partners Wealth | Unchanged | 79,365 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 78,204 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 78,204 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 75,660 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026